According to new ONS data, 36% of UK people who are vaccine hesitant have strong side effect fears - while a further 12% fear needles, and 22% think vaccines could impact fertility.
The National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health (NIH), drives the epilepsy field ahead with new research benchmarks, Vicky Whittemore, PhD, Program Director reveals.
Dr Shireen Kassam MBBS, FRCPath, PhD, dipIBLM, Founder and Director of Plant-Based Health Professionals UK, explains a simple prescription for health as a remedy to chronic disease.
Dr Faye Riley, Senior Research Communications Officer at Diabetes UK, highlights how immunotherapy is raising hopes for the next big breakthrough in type 1 diabetes.
Here, Kristoffer Petersson, MRC Investigator and Group Leader of FLASH Radiation, enlightens us to the benefits of this promising new radiotherapy technique.
Jason W. Loxterkamp and Pamela J. Lein from University of California, Davis, explore the therapeutic potential of psychedelic drugs in patients with psychiatric disorders.
Dr Deborah J Lee, Dr Fox Online Pharmacy, tells us everything we need to know about personality disorders, including how they are diagnosed and treated.
The safety committee of the European Medicines Agency said the investigation did not prove that AstraZeneca vaccinations cause blood clots - describing the possibility as an "extremely small likelihood".
Over the weekend, the Republic of Ireland suspended their use of AstraZeneca due to reports of blood clots in Norway - in response, the European Medicines Agency (EMA) says the AstraZeneca vaccine is still safe to use.
The US based vaccine appears to be 96.4% effective against the original COVID mutation, with 86% efficacy against the UK variant and only 55% against the South African variant.
Rosie Copland-Mann, Creative Strategist at Rehab, discusses how digital therapies for mental health treatment has evolved, with a special focus on COVID-19.
Researchers at Yale believe that blood tests could predict severe or critical COVID cases, because blood holds a series of interesting biological signals about a person.
New data suggests that before 60 days of COVID symptoms beginning is the best window for convalescent plasma donation - which is how antibodies were created in countless COVID-19 patients before vaccines.
Michael Morrison, Senior Researcher in Social Science at the Centre for Health, Law and Emerging Technologies (HeLEX), University of Oxford, sheds light on the promises as well as biomodifying technologies for the UK.
Early stage data from the vaccine rollout in the UK appears to show that COVID hospitalisation and death are reduced by over 75% in people with the Pfizer vaccine.
